440 related articles for article (PubMed ID: 9851551)
21. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
22. Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells.
Imaeda A; Tanigawa T; Aoki T; Kondo Y; Nakamura N; Yoshikawa T
Free Radic Res; 2001 Dec; 35(6):789-801. PubMed ID: 11811530
[TBL] [Abstract][Full Text] [Related]
23. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis.
Yamamoto A; Itoh S; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on MPP(+)-induced hydroxyl radical in the rat striatum.
Obata T; Yamanaka Y
Brain Res; 2000 Mar; 860(1-2):166-9. PubMed ID: 10727637
[TBL] [Abstract][Full Text] [Related]
25. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
Obata T; Ebihara A; Yamanaka Y
Biochim Biophys Acta; 2001 Apr; 1536(1):55-63. PubMed ID: 11335104
[TBL] [Abstract][Full Text] [Related]
26. Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice.
Imaeda A; Kaneko T; Aoki T; Kondo Y; Nakamura N; Nagase H; Yoshikawa T
Food Chem Toxicol; 2002 Oct; 40(10):1415-22. PubMed ID: 12387303
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.
Suzumura K; Yasuhara M; Tanaka K; Suzuki T
Biochem Pharmacol; 1999 Mar; 57(6):697-703. PubMed ID: 10037456
[TBL] [Abstract][Full Text] [Related]
28. Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomes.
Toda T; Eliasson E; Ask B; Inotsume N; Rane A
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):327-32. PubMed ID: 19663817
[TBL] [Abstract][Full Text] [Related]
29. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
[TBL] [Abstract][Full Text] [Related]
30. Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells.
Hayashi K; Kurokawa J; Nomura S; Kuga Y; Ohkura Y; Kajiyama G
Biochim Biophys Acta; 1993 Apr; 1167(2):223-5. PubMed ID: 8466953
[TBL] [Abstract][Full Text] [Related]
31. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
[TBL] [Abstract][Full Text] [Related]
32. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
Fischer V; Johanson L; Heitz F; Tullman R; Graham E; Baldeck JP; Robinson WT
Drug Metab Dispos; 1999 Mar; 27(3):410-6. PubMed ID: 10064574
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on copper-induced hydroxyl radical generation in the rat heart.
Obata T
Toxicology; 2006 Jun; 223(3):175-80. PubMed ID: 16647179
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of rat liver microsomal lipid peroxidation by boldine.
Cederbaum AI; Kukiełka E; Speisky H
Biochem Pharmacol; 1992 Nov; 44(9):1765-72. PubMed ID: 1333206
[TBL] [Abstract][Full Text] [Related]
35. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes.
Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308
[TBL] [Abstract][Full Text] [Related]
36. Ferritin stimulation of lipid peroxidation by microsomes after chronic ethanol treatment: role of cytochrome P4502E1.
Kukiełka E; Cederbaum AI
Arch Biochem Biophys; 1996 Aug; 332(1):121-7. PubMed ID: 8806716
[TBL] [Abstract][Full Text] [Related]
37. Salicylic acid-induced lipid peroxidation in rat liver microsomes.
Doi H; Masubuchi Y; Narimatsu S; Nishigaki R; Horie T
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):265-71. PubMed ID: 9730006
[TBL] [Abstract][Full Text] [Related]
38. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
39. Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.
Misra HP; Rabideau C
Mol Cell Biochem; 2000 Jan; 204(1-2):119-26. PubMed ID: 10718632
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits.
Akira K; Amano M; Okajima F; Hashimoto T; Oikawa S
Biol Pharm Bull; 2006 Jan; 29(1):75-81. PubMed ID: 16394514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
